NL
DE
30 July 2020
The research will focus on a mechanism for gene regulation by small RNA molecules in mosquitoes. These small molecules will be used to destroy the living vaccine virus in the insect, when it is sucked up by a mosquito. This blockage will prevent an uncontrolled spread of the vaccine virus and thus prevent the return to a virulent, pathogenic form
The “VIVARNAsilencing2” project will first focus on human arboviruses that cause dangerous epidemics: the dengue, Zika, and chikungunya viruses. However, the approach is readily applicable for all arboviruses transmitted by Culex and Aedes mosquitoes, including those affecting farm animals. It therefore meets an urgent need, considering the enormous burden of mosquito-transmitted diseases and the strong global push to develop vaccines for them.
read more
The research will focus on a mechanism for gene regulation by small RNA molecules in mosquitoes. These small molecules will be used to destroy the living vaccine virus in the insect, when it is sucked up by a mosquito. This blockage will prevent an uncontrolled spread of the vaccine virus and thus prevent the return to a virulent, pathogenic form
The “VIVARNAsilencing2” project will first focus on human arboviruses that cause dangerous epidemics: the dengue, Zika, and chikungunya viruses. However, the approach is readily applicable for all arboviruses transmitted by Culex and Aedes mosquitoes, including those affecting farm animals. It therefore meets an urgent need, considering the enormous burden of mosquito-transmitted diseases and the strong global push to develop vaccines for them.
read more
Related news items
Grants for research on magnesium deficiency and malaria Vidis for Felix Hol and Jeroen de Baaij
1 July 2022 Radboudumc researchers Jeroen de Baaij and Felix Hol both receive an NWO Vidi grant for their research, respectively on magnesium deficiency in type 2 diabetes and on malaria. read more
Field research on malaria vaccine offers unexpected surprise
23 May 2022Field research on the effectiveness of a malaria vaccine, came up with unexpected results for an international group of researchers including Benjamin Mordmüller of Radboudumc. The vaccine evokes a broader response against malaria proteins than there are in the vaccine.
read more
